Skye Bioscience’s (SKYE) “Overweight” Rating Reiterated at Cantor Fitzgerald
5 Jul 06:52 · 1 article
Analysts Set Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Target Price at $59.11
5 Jul 06:58 · 1 article